A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2011
11/09/2011	CN101766577B Solid preparation of clopidogrel free alkali and preparation process thereof
11/09/2011	CN101693888B Yellow mealworm plasmin and preparation method and applications thereof
11/09/2011	CN101637450B Levocarnitine liposomes injection and its preparation method
11/09/2011	CN101585864B Nitrogen-terminal fixed-point coupling method for colony stimulating factor of column chromatography granulocyte and coupled product
11/09/2011	CN101549064B Medicament composition containing chilopod acting on NEI network and uses thereof
11/09/2011	CN101406621B Medicinal liquor for treating sequelae of cerebral thrombus
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101327284B Anticoagulant medicine made from Chinese medicine
11/09/2011	CN101200493B (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8052998 Mixture of biodegradable polymer and cationic polymer
11/08/2011	CA2702431C Ready-to-use bivalirudin compositions
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2476430C Sodium channel blockers
11/08/2011	CA2476054C Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2436180C Immunoregulatory antibodies and uses thereof
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011136791A1 Composition for preserving platelets and method of using and storing the same
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136313A1 High-purity soluble thrombomodulin and method for producing same
11/03/2011	WO2011135397A1 Antiplatelet agent and methods of using the same
11/03/2011	WO2011135308A1 Conjugated blood coagulation factor viia
11/03/2011	WO2011135307A1 Conjugated blood coagulation factor viii
11/03/2011	WO2011134369A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method
11/03/2011	WO2011107649A3 Peritoneal dialysis solution comprising aliskiren
11/03/2011	WO2011072266A3 Aminoacyl trna synthetases for modulating hematopoiesis
11/03/2011	US20110270381 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
11/03/2011	US20110269806 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
11/03/2011	US20110269799 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269776 Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269754 Compounds and compositions for reducing lipid levels
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
11/03/2011	US20110269721 Methods of treating thalassemia
11/03/2011	US20110269703 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
11/03/2011	US20110269700 Glucoside derivatives and uses thereof
11/03/2011	US20110269666 Method and drug composition for treating septic shock hypotension
11/03/2011	US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
11/03/2011	US20110268811 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
11/03/2011	US20110268800 Unsaturated fatty acids as thrombin inhibitors
11/03/2011	US20110268790 Snake Factor V and Methods of Use Thereof as a Procoagulant
11/03/2011	US20110268784 Clay-based hemostatic agents and devices for the delivery thereof
11/03/2011	US20110268781 Drug eluting composite
11/03/2011	US20110268745 Antibodies Against Tissue Factor Pathway Inhibitor (TFPI)
11/03/2011	US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268726 Anti-CD38 human antibodies and uses thereof
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268690 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/02/2011	EP2383272A1 Active blood coagulation factor inhibitor
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	EP2381780A1 Compositions comprising decitabine and tetrahydrouridine and uses thereof
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	CN1814048B Chinese medicine liquid capsule of Folium callicarpae Nudiflorae, preparing method and quality control method
11/02/2011	CN102229616A Tetrahydrothieno pyridine derivative, and preparation method and purpose thereof
11/02/2011	CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011	CN102228691A Aspirin and anticoagulant pharmaceutical composition
11/02/2011	CN102228683A Method for preparing freeze-dried human blood coagulation factor VIII
11/02/2011	CN102228680A Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof
11/02/2011	CN102228677A 21 (R) argatroban intravenous injection containing acid as solubiliser
11/02/2011	CN102228633A Traditional Chinese medicine for treating blood heat and toxic type nosebleed of children and preparation method thereof
11/02/2011	CN102228625A Method for brewing blood enriching nutrient solution
11/02/2011	CN102228620A Chinese medicinal compound preparation having the functions of supplementing iron and enriching the blood and preparation method thereof
11/02/2011	CN102228606A Traditional Chinese medicine composition for treating hematuria of foals
11/02/2011	CN102228603A Chinese medicine for treating retention of urine
11/02/2011	CN102228563A Traditional Chinese medicine preparation for treating paroxysmal nocturnal hemoglobinuria
11/02/2011	CN102228515A Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
11/02/2011	CN102228509A Film coating method of Chinese patent drug herba clinopodii tablets
11/02/2011	CN102228507A Method for extracting engelhardtia roxburghiana extract and engelhardtia roxburghiana extract capsules thereof
11/02/2011	CN102228500A Method for producing Euonymus hederaceus Champ. ex Benth preparation and application thereof
11/02/2011	CN102228498A Preparation method and application of total flavonoids in stem leaves of chrysanthemum
11/02/2011	CN102228487A Extraction method for saponin from Stauntonia brachyanthera Hand-Mazz
11/02/2011	CN102228452A Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
11/02/2011	CN102228446A Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof
11/02/2011	CN102228426A 21(R) argatroban intravenous injection with alcohol as solubilizer
11/02/2011	CN101508983B Method for separation and purification of natto kinase by using soybean particle as affinity matrix
11/02/2011	CN101502634B Chinese medicinal composition for treating uterine blood flow and preparation method thereof
11/02/2011	CN101190263B Rhubarb chewable tablets and preparation method and application thereof
11/01/2011	US8048452 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
11/01/2011	CA2640435C Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
11/01/2011	CA2596283C Embolization using poly-4-hydroxybutyrate particles
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2375910C Tanacetum parthenium extract
10/2011
10/27/2011	WO2011133685A2 Nanoparticle targeting to ischemia for imaging and therapy
10/27/2011	WO2011133434A1 Methods of treating glucose metabolism disorders
10/27/2011	WO2011133204A1 Methods and assays for treating or preventing obesity and/or diabetes or increasing insulin sensitivity
10/27/2011	WO2011132633A1 Substituted 5-hydroxypyrimidine-4-carboxamide compound

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 671